Agile Therapeutics (AGRX)
0.60
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K AGILE THERAPEUTICS INC For: Mar 22
March 25, 2024 4:31 PM - SEC Filing
Agile Therapeutics (AGRX) Announces Delisting
March 25, 2024 4:30 PM - StreetInsider
Agile Therapeutics Announces Delisting from Nasdaq
March 25, 2024 4:30 PM - StreetInsider
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
March 21, 2024 6:35 AM - StreetInsider
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
March 20, 2024 8:15 AM - StreetInsider
Maxim Group Downgrades Agile Therapeutics (AGRX) to Hold
March 18, 2024 7:56 AM - StreetInsider
Form 8-K AGILE THERAPEUTICS INC For: Mar 13
March 14, 2024 4:45 PM - SEC Filing
Agile Therapeutics (AGRX) Completes Pay-off of Debt
March 13, 2024 7:31 AM - StreetInsider
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
March 13, 2024 7:31 AM - Globe NewsWire
Form 424B5 AGILE THERAPEUTICS INC
February 23, 2024 5:00 PM - SEC Filing
Form 424B5 AGILE THERAPEUTICS INC
February 23, 2024 4:58 PM - SEC Filing
Form 8-K AGILE THERAPEUTICS INC For: Feb 22
February 23, 2024 4:37 PM - SEC Filing
Agile Therapeutics (AGRX) Receives $4.8M in Warrants Exercise Proceeds
February 22, 2024 9:03 AM - StreetInsider
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
February 22, 2024 9:02 AM - StreetInsider
Form 8-K AGILE THERAPEUTICS INC For: Feb 09
February 15, 2024 4:46 PM - SEC Filing
Agile Therapeutics (AGRX) Granted Nasdaq Extension to Regain Compliance
February 15, 2024 4:30 PM - StreetInsider
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
February 15, 2024 4:30 PM - Globe NewsWire
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
February 15, 2024 4:30 PM - StreetInsider
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: Lind Global Fund II LP
February 13, 2024 8:02 PM - SEC Filing
Form S-1/A AGILE THERAPEUTICS INC
February 7, 2024 4:52 PM - SEC Filing
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: INTRACOASTAL CAPITAL, LLC
February 6, 2024 10:15 AM - SEC Filing
Form S-1/A AGILE THERAPEUTICS INC
February 5, 2024 9:21 AM - SEC Filing
Form S-1/A AGILE THERAPEUTICS INC
February 2, 2024 4:27 PM - SEC Filing
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
January 23, 2024 9:29 AM - StreetInsider
Full Article List